Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
BigCommerce President Travis Hess compares BigCommerce versus Shopify.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Brent is the Chief Executive Officer of BigCommerce.
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
A2A highlights Andres Acebo and features a CEO spotlight on Priscilla Almodovar joining Fannie Mae as CEO.
00:10:00
Tommy Discusses Burkina Faso Exploration Plans Ahead of ASX Listing
00:10:00
Achieving Chartered Financial Modeler (CFM) Accreditation: What You Need to Know | Ian Schnoor, Executive Director ,Financial Modeling Institute.
00:10:00
Accelerating Electric Vehicle Adoption: Challenges and Imperatives for New Zealand |Fraser Whineray, CEO, Mercury Nz Ltd.
00:10:00
Business of Biotech- Trends in Life Science Funding & Exits|Tim Shannon,General Partner,Canaan Partners
00:10:00
Technological Advancements: A Threat to Text-Based Communication|Josh Coyne,Partner,Kleiner
00:10:00
Anil Sharma, CEO & Founder of GMS, commemorates their First Foundation Day alongside a Men's First Team Training Session.
00:10:00
Stephen Cornish Discusses Pentanet's Impact on Western Australia's Internet Landscape | Stephen Cornish, Founder , Pentanet Ltd.
00:00:00
Ceapro using patented technology to disrupt the natural health care products - Gilles Gagnon, President and Chief Executive Officer, Ceapro
00:10:00
The March to Marxism: Addressing Cancel Culture and Law Enforcement Challenges|Joshua David Hawley
00:10:00
The keys to building a successful DeFi project|Tarun Chitra,Partner,Robot Ventures
00:10:00
BBVA Asset Management Market Focus – March 2022: Embracing Diversification with Private Markets